141 related articles for article (PubMed ID: 27455551)
1. Mucoadhesive dexamethasone acetate-polymyxin B sulfate cationic ocular nanoemulsion--novel combinatorial formulation concept.
Li X; Müller RH; Keck CM; Bou-Chacra NA
Pharmazie; 2016 Jun; 71(6):327-33. PubMed ID: 27455551
[TBL] [Abstract][Full Text] [Related]
2. Development of cationic nanocrystals for ocular delivery.
Romero GB; Keck CM; Müller RH; Bou-Chacra NA
Eur J Pharm Biopharm; 2016 Oct; 107():215-22. PubMed ID: 27388629
[TBL] [Abstract][Full Text] [Related]
3. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate.
Yamaguchi M; Yasueda S; Isowaki A; Yamamoto M; Kimura M; Inada K; Ohtori A
Int J Pharm; 2005 Sep; 301(1-2):121-8. PubMed ID: 16023810
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of preservative systems in opthalmic suspension of polymyxin B and dexamethasone by linear regression.
Bou-Chacra NA; Pinto TJ; Kaneko TM
Pharmazie; 2007 Mar; 62(3):199-204. PubMed ID: 17416196
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
[TBL] [Abstract][Full Text] [Related]
7. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
Sharma S; Sahni JK; Ali J; Baboota S
Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
[TBL] [Abstract][Full Text] [Related]
8. Development of a liquid chromatographic method for ear drops containing neomycin sulphate, polymyxin B sulphate and dexamethasone sodium phosphate.
Pendela M; Adams E; Hoogmartens J
J Pharm Biomed Anal; 2004 Nov; 36(4):751-7. PubMed ID: 15533667
[TBL] [Abstract][Full Text] [Related]
9. Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees C.
He J; Figueroa DA; Lim TP; Chow DS; Tam VH
Am J Health Syst Pharm; 2010 Jul; 67(14):1191-4. PubMed ID: 20592326
[TBL] [Abstract][Full Text] [Related]
10. Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of Polymyxin B.
Pattani AS; Mandawgade SD; Patravale VB
J Nanosci Nanotechnol; 2006; 6(9-10):2986-90. PubMed ID: 17048508
[TBL] [Abstract][Full Text] [Related]
11. Nanocarrier-based topical drug delivery for an antifungal drug.
Hussain A; Samad A; Nazish I; Ahmed FJ
Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
[TBL] [Abstract][Full Text] [Related]
12. Development and bioavailability assessment of ramipril nanoemulsion formulation.
Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
[TBL] [Abstract][Full Text] [Related]
13. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
14. Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion.
Rahman Z; Xu X; Katragadda U; Krishnaiah YS; Yu L; Khan MA
Mol Pharm; 2014 Mar; 11(3):787-99. PubMed ID: 24423028
[TBL] [Abstract][Full Text] [Related]
15. Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment.
Jurišić Dukovski B; Juretić M; Bračko D; Randjelović D; Savić S; Crespo Moral M; Diebold Y; Filipović-Grčić J; Pepić I; Lovrić J
Int J Pharm; 2020 Feb; 576():118979. PubMed ID: 31870964
[TBL] [Abstract][Full Text] [Related]
16. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
Swaminathan S; Vavia PR; Trotta F; Cavalli R
J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
[TBL] [Abstract][Full Text] [Related]
17. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
Lu Y; Wang Y; Tang X
Int J Pharm; 2008 Jan; 346(1-2):47-56. PubMed ID: 17640833
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery.
Kumar M; Misra A; Pathak K
PDA J Pharm Sci Technol; 2009; 63(6):501-11. PubMed ID: 20169856
[TBL] [Abstract][Full Text] [Related]
19. Studies on ocular and parenteral application potentials of azithromycin- loaded anionic, cationic and neutral-charged emulsions.
Tamilvanan S; Khanum R; Senthilkumar SR; Muthuraman M; Rajasekharan T
Curr Drug Deliv; 2013 Oct; 10(5):572-86. PubMed ID: 23721117
[TBL] [Abstract][Full Text] [Related]
20. Development of new ophthalmic suspension prednisolone acetate 1%.
Akram M; Shyum SB; Gauhar S
Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
